Type of security: Stock
Sector: Health Care
Industry: Major Pharmaceuticals
Market Capitalization: 1.85 B
The data is delayed by 15 minutes.
CBM is in the long-term up 176% above S&P in 13 years.
Description: Cambrex Corporation, a life sciences company, provides various products and services for the development and commercialization of new and generic therapeutics worldwide. Its products consist of active pharmaceutical ingredients and pharmaceutical intermediates that are used in the production of prescription and over-the-counter drug products. The company serves generic drug companies, and companies that discover and commercialize new small molecule human therapeutics. The company sells its products directly, as well as through independent agents. Cambrex Corporation was founded in 1981 and is headquartered in East Rutherford, New Jersey.
See how to gain 20% in 14 sec with TrendsInvesting
|Shares Outstanding||31.98 M||EPS||2.85||EPS Growth - 4 Quarters||EPS Growth - Q/Q|
|EPS Growth - Y/Y||Sales Growth - 4 Quarters||-20.81%||Sales Growth - Q/Q||-40.05%||P/E||20.14|
|P/E To EPS Growth||P/S||4.8||P/BV||7.6||Price/Cash Per Share|
|Price/Free Cash Flow||44.54||ROA||13.37%||ROE||26.34%||ROI||17.57%|
|Current Ratio||2.2||Quick Ratio||1.18||Long Term Debt/Equity||0.47||Debt Ratio||0.43|
|Gross Margin||35.31%||Operating Margin||16.19%||Net Profit Margin||16.66%||Dividend Payout Ratio|
|Cash From Financing Activities||1.6 M||Cash From Investing Activities||-12.04 M||Cash From Operating Activities||35.37 M||Gross Profit||29.08 M|
|Net Profit||7.99 M||Operating Profit||12.67 M||Total Assets||481.08 M||Total Current Assets||233.17 M|
|Total Current Liabilities||106.17 M||Total Debt||60 M||Total Liabilities||236.88 M||Total Revenue||77.53 M|
|High 52 week||67.4||Low 52 week||42.65||Last close||67||Last change||-0.59%|
|RSI||81.19||Average true range||1.57||Beta||1.22||Volume||174.76 K|
|Simple moving average 20 days||4.97%||Simple moving average 50 days||12.6%||Simple moving average 200 days||25.82%|
|Performance Week||3.47%||Performance Month||5.1%||Performance Quart||46.29%||Performance Half||25.82%|
|Performance Year||28.6%||Performance Year-to-date||39.58%||Volatility daily||1.48%||Volatility weekly||3.32%|
|Volatility monthly||6.8%||Volatility yearly||23.56%||Relative Volume||145.8%||Average Volume||386.69 K|
|New High||New Low|
2019-03-19 09:47:14 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-03-14 08:00:00 | Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan
2019-03-13 15:38:56 | Do You Like Cambrex Corporation NYSE:CBM At This P/E Ratio?
2019-03-12 09:30:01 | Should Value Investors Pick Cambrex Corporation CBM Stock?
2019-02-18 08:03:31 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-02-17 08:20:00 | 3 Top Biotech Stocks to Buy in February
2019-02-15 09:19:51 | CBM Missed Earnings by Over 90%
2019-02-13 15:58:24 | Cambrex Corp CBM Q4 2018 Earnings Conference Call Transcript
2019-02-13 11:25:00 | Why Cambrex Corporation Is Tanking Today
2019-02-13 08:05:01 | Cambrex CBM Surpasses Q4 Earnings Estimates
2019-02-13 07:10:40 | Cambrex: 4Q Earnings Snapshot
2019-02-13 06:40:00 | Cambrex Reports Fourth Quarter and Full Year 2018 Financial Results
2019-02-11 09:24:02 | Cambrex CBM Upgraded to Buy: Here's What You Should Know
2019-02-01 08:01:47 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-01-31 09:30:02 | CBM or ILMN: Which Is the Better Value Stock Right Now?
2019-01-30 08:01:44 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-01-24 08:02:41 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-01-18 09:10:02 | Is Cambrex CBM a Great Value Stock Right Now?
2019-01-16 08:01:49 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-01-15 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.
2019-01-09 09:30:02 | CBM or ALKS: Which Is the Better Value Stock Right Now?
2019-01-08 11:35:40 | Have Insiders Been Selling Cambrex Corporation NYSE:CBM Shares?
2019-01-02 09:40:00 | Cambrex Completes Acquisition of Avista Pharma Solutions
2018-12-24 08:01:31 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-12-18 06:49:46 | Hedge Funds Are Crazy About Cambrex Corporation CBM
2018-12-17 07:30:00 | Pharmaceutical ingredient manufacturer plans expansion in High Point
2018-12-13 08:02:42 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-12-11 10:32:22 | Cambrex Expands Analytical Capabilities at its High Point, NC Site
2018-12-11 08:02:47 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-12-08 08:02:38 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-11-22 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-11-20 13:02:21 | [$$] Cambrex Buying Avista Pharma Solutions From Ampersand for $252 Million
2018-11-20 06:40:00 | Cambrex to Acquire Avista Pharma Solutions, Adding Early Stage API and Finished Dosage Form Development & Testing Services to its Global Contract Development & Manufacturing Network
2018-11-15 08:01:42 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-11-13 08:01:43 | See what the IHS Markit Score report has to say about Cambrex Corp.
2018-11-09 10:47:01 | Cleantech Building Materials: Amendment of Loan Facility
2018-11-08 17:16:50 | Edited Transcript of CBM earnings conference call or presentation 8-Nov-18 1:30pm GMT
2018-11-08 11:57:27 | Cambrex Corp CBM Q3 2018 Earnings Conference Call Transcript
2018-11-08 10:45:03 | Cambrex CBM Lags Q3 Earnings and Revenue Estimates
2018-11-08 10:14:14 | What Investors Should Know About Cambrex Corporation’s NYSE:CBM Financial Strength
2018-11-08 09:38:13 | Cambrex: 3Q Earnings Snapshot
2018-11-08 06:40:00 | Cambrex Reports Third Quarter 2018 Financial Results
2018-11-05 15:55:00 | Cambrex to Announce Third Quarter 2018 Financial Results on November 8, 2018
2018-11-05 08:52:12 | Cambrex Corporation NYSE:CBM: Should The Future Outlook Worry You?
2018-10-30 17:01:00 | 3 Top Biotech Stocks to Buy Right Now
2018-10-29 13:47:21 | These Fundamentals Make Cambrex Corporation NYSE:CBM Truly Worth Looking At